Skip to content
SAMDI Tech
Better. Faster. Label-Free.
  • Why Label-Free Assays
  • Drug Discovery Solutions
    • Overview
    • Assay Development
    • High-Throughput Screening
    • SAMDI Affinity Selection Mass Spectrometry (ASMS) Technology
    • Small Molecule Compound Libraries
    • Cell-Based Assays
    • Substrate Specificity Profiling
    • Beyond Label-Free
      • Optical Assay Solutions
      • Radioactivity Assay Solutions
  • Scientific Resources
  • About Us
    • About Us
    • Executive Leadership
    • Board of Directors
    • Strategic Partnerships
    • Recognition and Awards
    • News
    • Events
    • Careers
  • Contact Us
  • Careers
  • Search

News

SAMDI Tech, Inc announces publication with Epizyme for characterizing CARM1 methyltransferase

February 22, 2016

Read More: https://www.ncbi.nlm.nih.gov/pubmed/26848779

Back to News

  • Privacy Policy
  • Contact Us

SAMDI Tech, Inc.
3440 South Dearborn Street
Suite 220S
Chicago, IL 60616

Phone: 312.235.3575

© 2023 SAMDI Tech, Inc. All rights reserved.

Connect with us on
  • Why Label-Free Assays
  • Drug Discovery Solutions
    • Overview
    • Assay Development
    • High-Throughput Screening
    • SAMDI Affinity Selection Mass Spectrometry (ASMS) Technology
    • Small Molecule Compound Libraries
    • Cell-Based Assays
    • Substrate Specificity Profiling
    • Beyond Label-Free
      • Optical Assay Solutions
      • Radioactivity Assay Solutions
  • Scientific Resources
  • About Us
    • About Us
    • Executive Leadership
    • Board of Directors
    • Strategic Partnerships
    • Recognition and Awards
    • News
    • Events
    • Careers
  • Contact Us
  • Careers
  • Search